Regulatory News
Thursday, November 17, 2016
UPDATE 1-Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
* Japan set cut due to high price of drug, Ono confirms
(Adds Japan price details)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment